Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lobna Ibrahim

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Bipolar Disorders|September 18, 2012
Family history of alcohol dependence and antidepressant response to an N-methyl-D-aspartate antagonist in bipolar depressionDavid A Luckenbaugh, Lobna Ibrahim, Nancy Brutsche, et al.
Journal of Clinical Psychopharmacology|June 23, 2012
A Randomized, placebo-controlled, crossover pilot trial of the oral selective NR2B antagonist MK-0657 in patients with treatment-resistant major depressive disorderLobna Ibrahim, Nancy Diaz Granados, Libby Jolkovsky, et al.
Thescientificworldjournal|April 27, 2010
New therapeutic targets for mood disordersRodrigo Machado-Vieira, Giacomo Salvadore, Nancy DiazGranados, et al.
Bipolar Disorders|October 10, 2013
Neural correlates of rapid antidepressant response to ketamine in bipolar disorderAllison C Nugent, Nancy Diazgranados, Paul J Carlson, et al.
British Journal of Clinical Pharmacology|February 3, 2012
Simultaneous population pharmacokinetic modelling of ketamine and three major metabolites in patients with treatment-resistant bipolar depressionXiaochen Zhao, Swarajya Lakshmi Vattem Venkata, Ruin Moaddel, et al.
Biological Psychiatry|February 3, 2012
Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trialCarlos A Zarate, Nancy E Brutsche, Lobna Ibrahim, et al.
Biological Psychiatry|December 5, 2012
A randomized trial of a low-trapping nonselective N-methyl-D-aspartate channel blocker in major depressionCarlos A Zarate, Daniel Mathews, Lobna Ibrahim, et al.
Biological Psychiatry|April 2, 2013
Neural correlates of rapid antidepressant response to ketamine in treatment-resistant unipolar depression: a preliminary positron emission tomography studyPaul J Carlson, Nancy Diazgranados, Allison C Nugent, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 3, 2012
Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled studyLobna Ibrahim, Nancy Diazgranados, Jose Franco-Chaves, et al.
Archives of General Psychiatry|August 4, 2010
A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depressionNancy Diazgranados, Lobna Ibrahim, Nancy E Brutsche, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Bipolar Disorders|September 18, 2012
Family history of alcohol dependence and antidepressant response to an N-methyl-D-aspartate antagonist in bipolar depressionDavid A Luckenbaugh, Lobna Ibrahim, Nancy Brutsche, et al.
Journal of Clinical Psychopharmacology|June 23, 2012
A Randomized, placebo-controlled, crossover pilot trial of the oral selective NR2B antagonist MK-0657 in patients with treatment-resistant major depressive disorderLobna Ibrahim, Nancy Diaz Granados, Libby Jolkovsky, et al.
Thescientificworldjournal|April 27, 2010
New therapeutic targets for mood disordersRodrigo Machado-Vieira, Giacomo Salvadore, Nancy DiazGranados, et al.
Bipolar Disorders|October 10, 2013
Neural correlates of rapid antidepressant response to ketamine in bipolar disorderAllison C Nugent, Nancy Diazgranados, Paul J Carlson, et al.
British Journal of Clinical Pharmacology|February 3, 2012
Simultaneous population pharmacokinetic modelling of ketamine and three major metabolites in patients with treatment-resistant bipolar depressionXiaochen Zhao, Swarajya Lakshmi Vattem Venkata, Ruin Moaddel, et al.
Biological Psychiatry|February 3, 2012
Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trialCarlos A Zarate, Nancy E Brutsche, Lobna Ibrahim, et al.
Biological Psychiatry|December 5, 2012
A randomized trial of a low-trapping nonselective N-methyl-D-aspartate channel blocker in major depressionCarlos A Zarate, Daniel Mathews, Lobna Ibrahim, et al.
Biological Psychiatry|April 2, 2013
Neural correlates of rapid antidepressant response to ketamine in treatment-resistant unipolar depression: a preliminary positron emission tomography studyPaul J Carlson, Nancy Diazgranados, Allison C Nugent, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 3, 2012
Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled studyLobna Ibrahim, Nancy Diazgranados, Jose Franco-Chaves, et al.
Archives of General Psychiatry|August 4, 2010
A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depressionNancy Diazgranados, Lobna Ibrahim, Nancy E Brutsche, et al.
Pageof 2